Kavya Ramkumar

2.0k citations

20 papers · 545 indexed · h-index 11

Impact in

Virology top 5%
- HIV Research and Treatment
Oncology
- Lung Cancer Research Studies
- PARP inhibition in cancer therapy

Papers in ⓘ

Oncology 13
- Lung Cancer Research Studies 7
- Pancreatic and Hepatic Oncology Research 4
Molecular Biology 8
- Cancer therapeutics and mechanisms 3

Co-authors: Nouri Neamati (4 shared papers)Srinivas Odde (3 shared papers)Erik Serrao (3 shared papers)Lauren A. Byers (15 shared papers)Carl M. Gay (11 shared papers)C. Allison Stewart (10 shared papers)Li Shen (8 shared papers)Jing Wang (5 shared papers)
Journals: Cancer Research (4 papers)Annals of Oncology (3 papers)Molecular Cancer Therapeutics (2 papers)Molecular Cancer Research (1 paper)Clinical Cancer Research (1 paper)
Partner nations: United States Italy South Korea

In The Last Decade

Kavya Ramkumar

20 papers receiving 534 citations

Peers

Countries citing papers authored by Kavya Ramkumar

Since Specialization

Citations

This map shows the geographic impact of Kavya Ramkumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kavya Ramkumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kavya Ramkumar more than expected).

Fields of papers citing papers by Kavya Ramkumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kavya Ramkumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kavya Ramkumar. The network helps show where Kavya Ramkumar may publish in the future.

Co-authors

The 25 scholars most cited alongside Kavya Ramkumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kavya Ramkumar Line = papers co-authored together Kavya Ramkumar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors Retrovirology ·Erik Serrao, Srinivas Odde, Kavya Ramkumar, Nouri Neamati	2009	125
2	Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC Journal of Thoracic Oncology ·Triparna Sen, Carminia Maria Della Corte, Snezana Milutinovic, Robert J. Cardnell, Lixia Diao, Kavya Ramkumar, Carl M. Gay, C. Allison Stewart, You-Hong Fan, Li Shen, Ryan J. Hansen, Bryan Strouse, Michael P. Hedrick, Christian A. Hassig, John V. Heymach, Jing Wang, Lauren A. Byers	2019	91
3	The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress–Mediated Apoptosis in Pancreatic Cancer Cancer Research ·Soma Samanta, Suhui Yang, Bikash Debnath, Ding Xue, Yuting Kuang, Kavya Ramkumar, Amy S. Lee, Mats Ljungman, Nouri Neamati	2021	78
4	Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer SHILAP Revista de lepidopterología ·Kasey R. Cargill, C. Allison Stewart, Elizabeth M. Park, Kavya Ramkumar, Carl M. Gay, Robert J. Cardnell, Qi Wang, Lixia Diao, Li Shen, You-Hong Fan, Wai Kin Chan, Philip L. Lorenzi, Trudy G. Oliver, Jing Wang, Lauren A. Byers	2021	41
5	AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors Molecular Cancer Research ·Kavya Ramkumar, C. Allison Stewart, Kasey R. Cargill, Carminia Maria Della Corte, Qi Wang, Li Shen, Lixia Diao, Robert J. Cardnell, David H. Peng, B. Leticia Rodriguez, You-Hong Fan, John V. Heymach, Jing Wang, Carl M. Gay, Don L. Gibbons, Lauren A. Byers	2020	38
6	A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers British Journal of Cancer ·Bingnan Zhang, Kavya Ramkumar, Robert J. Cardnell, Carl M. Gay, C. Allison Stewart, Wei‐Lien Wang, Junya Fujimoto, Ignacio I. Wistuba, Lauren A. Byers	2021	37
7	Discovery of 3-acetyl-4-hydroxy-2-pyranone derivatives and their difluoridoborate complexes as a novel class of HIV-1 integrase Inhibitors Bioorganic & Medicinal Chemistry ·Kavya Ramkumar, K. V. Tambov, Rambabu Gundla, A. V. Manaev, V. N. Yarovenko, V. F. Traven, Nouri Neamati	2008	34
8	HIV-1 integrase inhibitors: 2007-2008 update Medicinal Research Reviews ·Kavya Ramkumar, Erik Serrao, Srinivas Odde, Nouri Neamati	2010	32
9	SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer Translational Lung Cancer Research ·Kiran Kundu, Robert J. Cardnell, Bingnan Zhang, Li Shen, C. Allison Stewart, Kavya Ramkumar, Kasey R. Cargill, Jing Wang, Carl M. Gay, Lauren A. Byers	2021	29
10	Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer Clinical Cancer Research ·Kavya Ramkumar, Azusa Tanimoto, Carminia M. Della Corte, C. Allison Stewart, Qi Wang, Li Shen, Robert J. Cardnell, Jing Wang, Urszula M. Polanska, Courtney L. Andersen, Jamal Saeh, J. Elizabeth Pease, Jon Travers, Giulia Fabbri, Carl M. Gay, Jelena Urosevic, Lauren A. Byers	2023	14
11	1735P SARS-CoV-2 infection induces EMT-like molecular changes, including ZEB1-mediated repression of the viral receptor ACE2, in lung cancer models Annals of Oncology ·C. Allison Stewart, Carl M. Gay, Kavya Ramkumar, Kasey R. Cargill, Robert J. Cardnell, Monique B. Nilsson, Simon Heeke, E.M. Park, Samrat T. Kundu, Lixia Diao, Qianxia Wang, Li Shen, Yin Xi, Carminia Maria Della Corte, Kiran Kundu, Don L. Gibbons, Jie Wang, John V. Heymach, Lauren A. Byers	2020	10
12	Activity of the novel Aurora kinase B inhibitor AZD2811 in biomarker-defined models of small cell lung cancer Annals of Oncology ·Carminia Maria Della Corte, L. Ajpacaja, Robert J. Cardnell, C.M. Gay, Qianxia Wang, Li Shen, Kavya Ramkumar, Allison Stewart, You Hong Fan, Carrie A. Adelman, Jon Travers, Jie Wang, John V. Heymach, Lauren A. Byers	2019	4
13	1736P Elevated AXL expression following SARS-CoV-2 infection in non-small cell lung cancer Annals of Oncology ·Kavya Ramkumar, C. Allison Stewart, Carl M. Gay, Robert J. Cardnell, Li Diao, Q. Wang, Lin Shen, Yong Xi, Samrat T. Kundu, C. Della Corte, Don L. Gibbons, J. Wang, John V. Heymach, Lauren A. Byers	2020	2
14	900 Depleting non-canonical, cell-intrinsic PD-L1 signals induces synthetic lethality to small molecule DNA damage response inhibitors in an immune independent and dependent manner SHILAP Revista de lepidopterología ·Anand Kornepati, Clare Murray, Bárbara de la Peña Avalos, Cody M. Rogers, Kavya Ramkumar, Harshita B. Gupta, Yilun Deng, Zexuan Liu, Álvaro Padrón, Ratna K. Vadlamudi, Eloïse Dray, Weixing Zhao, Patrick Sung, Lauren A. Byers, Tyler J. Curiel	2021	2
15	Abstract 6206: Combined inhibition of AXL and ATR enhances replication stress, cell death and immune response in small cell lung cancer Cancer Research ·Kavya Ramkumar, C. Allison Stewart, Azusa Tanimoto, Qi Wang, Yuanxin Xi, Benjamin B. Morris, Runsheng Wang, Li Shen, Robert J. Cardnell, Jing Wang, Carl M. Gay, Lauren A. Byers	2023	2
16	Abstract B064: The Aurora kinase A-inhibitor, alisertib, is a potential candidate for combination with immunotherapy in small cell lung cancer Molecular Cancer Therapeutics ·Carminia Maria Della Corte, L. Ajpacaja, Robert J. Cardnell, Carl M. Gay, Lixia Diao, Qi Wang, Kavya Ramkumar, Allison Stewart, Rebecca B. Kow, Hannah E. Stumpf, You-Hong Fan, Jing Wang, John V. Heymach, Lauren A. Byers	2019	2
17	Abstract B024: Clinical, genomic, and immune landscape of the receptor tyrosine kinase AXL in non-small cell lung cancer Molecular Cancer Therapeutics ·Kavya Ramkumar, Carminia Maria Della Corte, Lixia Diao, Robert J. Cardnell, Vali A. Papadimitrakopoulou, John V. Heymach, Jing Wang, Don L. Gibbons, Lauren A. Byers	2019	1
18	Abstract 3196: Subtype-specific targeting of cell surfaceome with CAR T therapies in small cell lung cancer Cancer Research ·Bingnan Zhang, Yan Yang, C. Allison Stewart, Kavya Ramkumar, Runsheng Wang, Robert J. Cardnell, Lixia Diao, Qi Wang, Jing Wang, Lauren A. Byers, Carl M. Gay, John V. Heymach	2023	1
19	ChemInform Abstract: HIV‐1 Integrase Inhibitors: 2007—2008 Update ChemInform ·Kavya Ramkumar, Erik Serrao, Srinivas Odde, Nouri Neamati	2010	1
20	Abstract 276: Targeting AXL sensitizes non-small cell lung cancer to ATR inhibitors by enhancing replication stress Cancer Research ·Kavya Ramkumar, Pan Tong, You-Hong Fan, David H. Peng, John V. Heymach, Don L. Gibbons, Jing Wang, Lauren A. Byers	2019	1

About Kavya Ramkumar

Kavya Ramkumar is a scholar working on Oncology, Molecular Biology, Immunology, Epidemiology and Cell Biology, having authored 20 papers that have together received 545 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (7 papers), Phagocytosis and Immune Regulation (5 papers), HIV Research and Treatment (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Neuroendocrine Tumor Research Advances (4 papers), HIV/AIDS drug development and treatment (4 papers), Microtubule and mitosis dynamics (4 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Virology (109 citations), Oncology (213 citations), Infectious Diseases (140 citations), Molecular Biology (263 citations) and Cell Biology (60 citations). Kavya Ramkumar has collaborated with scholars based in United States, Italy and South Korea. Frequent co-authors include Nouri Neamati, Srinivas Odde, Erik Serrao, Lauren A. Byers, Carl M. Gay, C. Allison Stewart, Li Shen, Jing Wang, Robert J. Cardnell and You-Hong Fan. Their work appears in journals such as Cancer Research, Annals of Oncology, Molecular Cancer Therapeutics, Molecular Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact